Covered recipient · General Payments record
MONIQUE R ANDERSON
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2022–2025
$1,973.38
- Reported across 29 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,063.65 | 19 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $678.17 | 15 |
| TG THERAPEUTICS, INC. | $183.50 | 2 |
| Biogen, Inc. | $119.86 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $82.12 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (19)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $120.81 | 02/05/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228460776 | CMS |
| Amgen Inc. | $20.27 | 02/06/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228460788 | CMS |
| Amgen Inc. | $7.16 | 02/20/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1227102406 | CMS |
| Amgen Inc. | $109.22 | 03/05/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228460778 | CMS |
| Amgen Inc. | $17.02 | 03/06/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228460784 | CMS |
| Amgen Inc. | $13.00 | 04/17/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1227102404 | CMS |
| Amgen Inc. | $17.02 | 04/17/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228460786 | CMS |
| Amgen Inc. | $20.86 | 05/08/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228460792 | CMS |
| Amgen Inc. | $19.05 | 05/15/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228460790 | CMS |
| Amgen Inc. | $6.76 | 05/23/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1227102408 | CMS |
| Amgen Inc. | $21.65 | 07/17/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228460782 | CMS |
| Amgen Inc. | $145.24 | 09/16/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228460770 | CMS |
| Amgen Inc. | $114.90 | 10/23/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228460774 | CMS |
| Amgen Inc. | $22.04 | 10/24/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228460772 | CMS |
| Amgen Inc. | $23.17 | 11/04/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228460780 | CMS |
| Biogen, Inc. | $119.86 | 04/02/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1208448329 | CMS |
| Novartis Pharmaceuticals Corporation | $82.12 | 03/19/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1200205158 | CMS |
| TG Therapeutics, Inc. | $91.75 | 08/02/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1226235648 | CMS |
| TG Therapeutics, Inc. | $91.75 | 08/13/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1226235627 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2022, 2023, 2024, 2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.